Company · CIK 1811764
POINT Biopharma Global Inc.
| CIK | 1811764 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | IN |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-20 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-265981 | 2022-07-01 | 2023-12-29 | 5 | |
| 333-258325 | 2021-07-30 | 2022-07-07 | 4 | |
| 333-239196 | 2020-06-15 | 2020-07-09 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-12-29 | EFFECTDeclared effective | 333-265981 | 9999999995-24-000028 |
| 2023-12-29 | EFFECTDeclared effective | 333-254600 | 9999999995-24-000026 |
| 2022-09-14 | 424B5Shelf takedown | 333-265981 | 0001628280-22-024904 |
| 2022-09-13 | 424B5Shelf takedown | 333-265981 | 0001628280-22-024854 |
| 2022-07-11 | EFFECTDeclared effective | 333-265981 | 9999999995-22-002019 |
| 2022-07-07 | EFFECTDeclared effective | 333-258325 | 9999999995-22-001977 |
| 2022-07-01 | S-3Shelf registered | 333-265981 | 0001628280-22-018378 |
| 2022-03-28 | EFFECTDeclared effective | 333-258325 | 9999999995-22-000731 |
| 2021-08-05 | EFFECTDeclared effective | 333-258325 | 9999999995-21-003069 |
| 2021-07-30 | S-1Registration filed | 333-258325 | 0001104659-21-098307 |
| 2021-06-09 | EFFECTDeclared effective | 333-254600 | 9999999995-21-002271 |
| 2020-07-09 | 424B4Final prospectus | 333-239196 | 0001047469-20-004057 |
| 2020-07-07 | EFFECTDeclared effective | 333-239196 | 9999999995-20-001692 |
| 2020-07-07 | S-1/AAmendment | 333-239196 | 0001047469-20-004002 |
| 2020-07-06 | S-1/AAmendment | 333-239196 | 0001047469-20-003963 |
| 2020-06-29 | S-1/AAmendment | 333-239196 | 0001047469-20-003885 |
| 2020-06-15 | S-1Registration filed | 333-239196 | 0001047469-20-003606 |
| 2020-05-14 | DRSDraft made public | 377-03172 | 0000912057-20-000160 |